» Articles » PMID: 17690028

Regulating Regulatory T Cells to Achieve Transplant Tolerance

Overview
Publisher Elsevier
Specialty Gastroenterology
Date 2007 Aug 11
PMID 17690028
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Regulatory T cells (Tregs) play crucial roles in both induction and maintenance of tolerance. This active immune regulation may contribute not only to the control of immune responses to self-antigens and thereby prevent autoimmune diseases, but also the control of responses to non-self molecules in adaptive immunity. Numerous experimental and clinical studies indicate that manipulating the balance between regulatory and responder T cells is an effective strategy to control immune responsiveness after transplantation.

Data Sources: Literature search was conducted using PubMed on the related subjects. Part of the material was based on the most recent work in the authors' laboratory.

Results: We propose some new strategies to achieve transplant tolerance in rodent animals via manipulating Treg function, including using histone deacetylase (HDAC) inhibitor to regulate Foxp3 transcription and enhance Treg suppression, induction of Treg-sparing apoptosis via Nur77, and identification of the co-inhibitory molecule herpes virus entry mediator (HVEM) as an effector molecule for Treg function.

Conclusion: Regulation of Treg function will definitely provide us very promising tools to achieve clinical tolerance in the future.

Citing Articles

Treatment of chronic kidney diseases with histone deacetylase inhibitors.

Liu N, Zhuang S Front Physiol. 2015; 6:121.

PMID: 25972812 PMC: 4411966. DOI: 10.3389/fphys.2015.00121.


Regulatory T-cell therapy in transplantation: moving to the clinic.

Tang Q, Bluestone J Cold Spring Harb Perspect Med. 2013; 3(11).

PMID: 24186492 PMC: 3808774. DOI: 10.1101/cshperspect.a015552.


Histone deacetylases as targets for treatment of multiple diseases.

Tang J, Yan H, Zhuang S Clin Sci (Lond). 2013; 124(11):651-62.

PMID: 23414309 PMC: 4568123. DOI: 10.1042/CS20120504.


Regulation of immune responses by histone deacetylase inhibitors.

Licciardi P, Karagiannis T ISRN Hematol. 2012; 2012:690901.

PMID: 22461998 PMC: 3313568. DOI: 10.5402/2012/690901.


Effects of nilotinib on regulatory T cells: the dose matters.

Fei F, Yu Y, Schmitt A, Rojewski M, Chen B, Greiner J Mol Cancer. 2010; 9:22.

PMID: 20113470 PMC: 2835656. DOI: 10.1186/1476-4598-9-22.